Find therapies in clinical trials near you – page 770

Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

Study on the Effectiveness of Autologous Tumor-Infiltrating Lymphocytes, Aldesleukin, Fludarabine Phosphate, and Cyclophosphamide in Advanced Solid Tumors

Study on the Effectiveness of Autologous Tumor-Infiltrating Lymphocytes, Aldesleukin, Fludarabine Phosphate, and Cyclophosphamide in Advanced Solid Tumors

Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

Study on Long-Term Safety and Effects of PTC518 for Patients with Huntington's Disease

Study on Long-Term Safety and Effects of PTC518 for Patients with Huntington's Disease

Study on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension

Study on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Study of LY3502970 for Adults with Obesity or Overweight and Related Health Issues

Study of LY3502970 for Adults with Obesity or Overweight and Related Health Issues

Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

Study of Elranatamab for Treating Relapsed or Refractory Multiple Myeloma in Patients Previously Treated with Three Drug Classes

Study of Elranatamab for Treating Relapsed or Refractory Multiple Myeloma in Patients Previously Treated with Three Drug Classes

Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis

Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis